Deployed Edwards Sapien prosthesis is always deformed  by Zegdi, Rachid et al.
Brief Clinical ReportsDeployed Edwards Sapien prosthesis is always deformedRachid Zegdi, MD, PhD,a,b,e Didier Blanchard, MD,a,c Paul Achouh, MD, PhD,b Antoine Lafont, MD, PhD,a,c,e
Alain Berrebi, MD,b Bernard Cholley, MD, PhD,a,d and Jean-Noe¨l Fabiani, MD,a,b,e Paris, FranceTABLE 1. Preoperative clinical characteristics and main risk factors




Age (y) 81 (62–96)
Gender (M/F) 10 (53)/9 (47)Data regarding stent geometry of the deployed Sapien
prosthesis (Edwards Lifesciences, Irvine, Calif) are lacking.
We report here the fluoroscopic morphologic analysis of the
stent shape after implantation of this prosthesis through a ret-
rograde transfemoral approach in high-risk surgical patients
with severe symptomatic aortic stenosis.
NYHA functional class: II/III/IV 11/7/1
Cardiac rhythm: sinus/AF/pacing 16/2/1
Coronary artery disease 11 (58)
Chronic renal failure (creatinine
clearance<50 mL/min)
8 (42)
Cerebrovascular disease 7 (37)
Previous cardiac surgery 5 (26)
Chronic obstructive pulmonary disease 3 (16)
History of chest irradiation 2 (10)
Hepatic cirrhosis 1 (5)
Logistic EuroSCORE (%) 20.6 (8–52)
M/F, Male/female; NYHA, New York Heart Association; AF, atrial fibrillation.PATIENTS AND METHODS
We reviewed the fluoroscopic data of 19 patients in whom a Sapien
prosthesis has been implanted. The study was approved by the local institu-
tional review board and all patients gave their informed consent. Main
preoperative clinical and echocardiographic data were reported in Tables
1 and 2.
The size of the implanted Sapien Edwards valves was 23 mm (n¼ 13) or
26 mm (n ¼ 6). At the end of each procedure, 2 perpendicular fluoroscopic
views of the implanted valve were obtained: the profile (or long axis) and
front (or short axis) view (Figure 1). The 3 points of the stent frame to which
the leaflets are attached at their commissural level were here designated as
‘‘commissural bands.’’
The proximal and distal diameters were measured on the profile view.
Measurements made on the short-axis view are depicted in Figure 2.
Data were expressed as median (range) for continuous variables and as
percentages for categorical variables.RESULTS
On the profile view, the stent shape was never rectangular.
The distal diameter was always larger than the proximal
diameter (median distal to proximal diameter ratio, 1.08;
range, 1.04–1.13). Two types of stent profiles were identi-
fied (Figure 3). The stent frame had a biconic or a truncated
conic aspect in 84% and 16% of cases, respectively.
On the front view, the rim of the projected image of the
stent was never strictly linear. In fact, a more or less extended
segment of the rim was linear (reflecting good alignment with
x-ray films) whereas the remaining was crescent-like (Fig-
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analysis. The stent projection was usually grossly circular or
elliptic.
The 3 projections of the commissural bands described an
easily identifiable triangle. The median relative difference
between the longest and the shortest side (or L value) within
a same triangle was 2.9% (range, 0%–16.4%). The shape
of this triangle was considered as grossly equilateral in all
but 3 cases (17.5%), where this difference exceeded
10%. The L/2H ratio was significantly higher than the the-
oretical value (median, 2.04 [range, 1.73–2.47] vs 1.73;
P< .0001), thus implying the noncircularity of the distal
part of the stent.TABLE 2. Preoperative echocardiographic data of the study
population
n (%) or median (range)
Aortic valve area (cm2) 0.53 (0.24–0.8)
Mean aortic gradient (mm Hg) 62 (24–110)
Aortic annulus diameter (mm) 21 (19–23)
Bicuspid aortic valve 0
Ejection fraction (%) 55 (17–77)




Septal thickness (mm) 12 (10–20)
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FIGURE 1. Fluoroscopic long-axis (left) and short-axis (right) views of an implanted Sapien Edwards valve. Note the crescent like zone (arrows) of the stent
projection on the short-axis view.
Brief Clinical ReportsDISCUSSION
The present fluoroscopic study revealed that, once de-
ployed, the Sapien prosthesis not only did not have a rectan-
gular aspect on the long-axis view but also that its distal
extremity (supporting the free edge of the leaflets) was never
strictly circular.
Although there are different ways to investigate stent ge-
ometry, the question of its utility may be raised. There is
a wide belief that valve durability is critically dependent on
stress distribution on leaflets.1,2 Stress on leaflets is dependent
on prosthesis design. One may assume that stress distribution
on leaflets in a ‘‘nondeformed’’ prosthesis as provided by
valve manufacturers has been minimized. In a previous study,
we3 have clearly shown that even a minor stent deformation
might be responsible for leaflet distortion. Abnormal stent
shape of the deployed Sapien prosthesis was shown to be con-
stant in the present study. We may therefore assume that thereFIGURE 2. Schematic representation of the main measurements of stent deplo
stent deployment, this ratio is independent of the stent diameter and should be equ
circular deployment of the stent. PD, Proximal diameter; ID, intermediate diam
The Journal of Thoracic and Cais an increase in stress on leaflets in these valves. Computer
modeling studies should confirm this hypothesis. The impact
of stent deformation on valve durability should also be inves-
tigated in ex vivo studies using pulse duplicators.
In the present fluoroscopic study, the stent shape was par-
ticularly investigated at the level of its distal extremity, that
one supporting the free edge of the leaflets. Leaflet to stent
mismatch was demonstrated in at least 17.5% of cases
(3/17), where the relative difference between the largest
and smallest intercommissural distance within a same stent
exceeded 10%. Leaflet to stent mismatch may be responsi-
ble for either leaflet restriction or leaflet prolapse in the most
severe forms. In both cases, intraprosthetic regurgitation
may occur as it has previously been reported.4
In summary, the present fluoroscopic study of the Sapien
prosthesis revealed that this prosthesis did not have a cylin-
drical deployment after full expansion. It also showedyment performed on the long-axis and short-axis views. In case of circular
al to tg(p/3)z 1.73. Conversely, alteration in this ratio would imply a non-
eter; DD, distal diameter; L, intercommissural distance.
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FIGURE 3. Two stent profiles were seen on the long-axis view. Fully deployed stents had a biconic (left) or a conic (right) aspect. Note the waist zone (*) on
the left.
Brief Clinical Reportsindirect evidence of leaflet tissue to stent mismatch in at least
17.5% of cases. The clinical impact of these new data will
have to be determined.References
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St Louis, MoThe management of heparin-induced thrombocytopenia
(HIT) remains a major clinical challenge in adults requiring
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tients with end-stage heart failure are particularly vulnerable
to the development of HIT owing to their frequent and long-
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performed.CLINICAL SUMMARY
The patient was a 47-year-old man with mild chronic
obstructive pulmonary disease and no significant medical his-
tory except for multiple recent hospitalizations for respiratory
decompensation, presumed to be secondary to exacerbation of
chronic obstructive pulmonary disease as well as pneumonia.
He was admitted to an outside institution with acute cardio-
genic shock, presumed to be secondary to acute viral myocar-
ditis, without any evidence of myocardial ischemia (negative
electrocardiographic findings, negative troponin levels). He
also had acute renal failure, hepatic ischemia with signifi-
cantly elevated transaminase levels, and rapid development
of respiratory failure necessitating emergency intubation. He
was started on inotropic support. An echocardiogram revealed
severe global biventricular hypokinesis with a left ventricular
ejection fraction of 7%, severe mitral and tricuspidery c September 2010
